ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Short Interest Update

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) saw a significant decrease in short interest in February. As of February 27th, there was short interest totaling 9,382 shares, a decrease of 50.0% from the February 12th total of 18,771 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily volume of 21,288 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 21,288 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.3% of the shares of the stock are short sold.

Hedge Funds Weigh In On ALPS Medical Breakthroughs ETF

Large investors have recently added to or reduced their stakes in the stock. Delta Investment Management LLC purchased a new position in ALPS Medical Breakthroughs ETF during the fourth quarter valued at $6,112,000. LPL Financial LLC raised its position in shares of ALPS Medical Breakthroughs ETF by 438.7% during the 4th quarter. LPL Financial LLC now owns 42,755 shares of the company’s stock worth $2,190,000 after purchasing an additional 34,819 shares during the last quarter. Griffin Asset Management Inc. boosted its holdings in ALPS Medical Breakthroughs ETF by 1.9% in the 4th quarter. Griffin Asset Management Inc. now owns 30,699 shares of the company’s stock worth $1,572,000 after buying an additional 564 shares during the last quarter. Jones Financial Companies Lllp purchased a new stake in ALPS Medical Breakthroughs ETF during the 1st quarter worth approximately $782,000. Finally, Moran Wealth Management LLC increased its stake in ALPS Medical Breakthroughs ETF by 22.7% during the 4th quarter. Moran Wealth Management LLC now owns 21,084 shares of the company’s stock worth $1,080,000 after buying an additional 3,897 shares in the last quarter.

ALPS Medical Breakthroughs ETF Stock Down 2.9%

Shares of ALPS Medical Breakthroughs ETF stock traded down $1.52 on Thursday, reaching $50.18. The company’s stock had a trading volume of 26,122 shares, compared to its average volume of 39,621. The stock has a 50-day moving average price of $51.20 and a 200-day moving average price of $46.22. ALPS Medical Breakthroughs ETF has a 52-week low of $22.33 and a 52-week high of $54.79.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.